DAGLB Antikörper (Middle Region)
Kurzübersicht für DAGLB Antikörper (Middle Region) (ABIN951834)
Target
Alle DAGLB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 497-527, Middle Region
-
Spezifität
- This antibody recognizes Human and Mouse DAGLB (Center).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 497~527 amino acids from the Center region of Human DAGLB. Genename: DAGLB
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- DAGLB (Diacylglycerol Lipase, beta (DAGLB))
-
Andere Bezeichnung
- DAGLB
-
Hintergrund
- Catalyzes the hydrolysis of diacylglycerol (DAG) to 2-arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses.Synonyms: DAGLBETA, DGL-beta, DGLb, FLJ33624, FLJ33909, FLJ45532, KCCR13L, Sn1-specific diacylglycerol lipase beta
-
Molekulargewicht
- 73732 Da (Isoform 3. 28899 Da)
-
Gen-ID
- 221955
-
NCBI Accession
- NP_001136408
Target
-